Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression.

Waikar SS, Srivastava A, Palsson R, Shafi T, Hsu CY, Sharma K, Lash JP, Chen J, He J, Lieske J, Xie D, Zhang X, Feldman HI, Curhan GC; Chronic Renal Insufficiency Cohort study investigators.

JAMA Intern Med. 2019 Mar 4. doi: 10.1001/jamainternmed.2018.7980. [Epub ahead of print]

PMID:
30830167
2.

Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.

Bowe B, Xie Y, Xian H, Li T, Al-Aly Z.

Clin J Am Soc Nephrol. 2017 Apr 3;12(4):603-613. doi: 10.2215/CJN.09710916. Epub 2017 Mar 27.

3.

Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).

Smith ER, Lee D, Cai MM, Tomlinson LA, Ford ML, McMahon LP, Holt SG.

Nephrol Dial Transplant. 2013 Jun;28(6):1569-79. doi: 10.1093/ndt/gfs586. Epub 2013 Jan 16.

PMID:
23328709
4.

Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure.

Zhao F, Bergstralh EJ, Mehta RA, Vaughan LE, Olson JB, Seide BM, Meek AM, Cogal AG, Lieske JC, Milliner DS; Investigators of Rare Kidney Stone Consortium.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):119-26. doi: 10.2215/CJN.02810315. Epub 2015 Dec 10.

5.

Urinary creatinine excretion, measured glomerular filtration rate and CKD outcomes.

Tynkevich E, Flamant M, Haymann JP, Metzger M, Thervet E, Boffa JJ, Vrtovsnik F, Houillier P, Froissart M, Stengel B; NephroTest Study Group.

Nephrol Dial Transplant. 2015 Aug;30(8):1386-94. doi: 10.1093/ndt/gfv047. Epub 2015 Mar 27.

PMID:
25817225
6.

Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.

Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI; CRIC Study Investigators.

Am J Kidney Dis. 2014 Feb;63(2):236-43. doi: 10.1053/j.ajkd.2013.08.028. Epub 2013 Oct 30.

7.

Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children.

Schaefer F, Trachtman H, Wühl E, Kirchner M, Hayek SS, Anarat A, Duzova A, Mir S, Paripovic D, Yilmaz A, Lugani F, Arbeiter K, Litwin M, Oh J, Matteucci MC, Gellermann J, Wygoda S, Jankauskiene A, Klaus G, Dusek J, Testa S, Zurowska A, Caldas Afonso A, Tracy M, Wei C, Sever S, Smoyer W, Reiser J; ESCAPE Trial Consortium and the 4C Study Group.

JAMA Pediatr. 2017 Nov 6;171(11):e172914. doi: 10.1001/jamapediatrics.2017.2914. Epub 2017 Nov 6. Erratum in: JAMA Pediatr. 2017 Nov 1;171(11):1127.

8.

Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study.

Tabibzadeh N, Wagner S, Metzger M, Flamant M, Houillier P, Boffa JJ, Vrtovsnik F, Thervet E, Stengel B, Haymann JP; NephroTest Study Group.

Am J Kidney Dis. 2019 Feb 15. pii: S0272-6386(19)30004-6. doi: 10.1053/j.ajkd.2018.12.024. [Epub ahead of print]

PMID:
30777634
9.

Cognitive Impairment and Progression of CKD.

Kurella Tamura M, Yaffe K, Hsu CY, Yang J, Sozio S, Fischer M, Chen J, Ojo A, DeLuca J, Xie D, Vittinghoff E, Go AS; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

Am J Kidney Dis. 2016 Jul;68(1):77-83. doi: 10.1053/j.ajkd.2016.01.026. Epub 2016 Mar 10.

10.

Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.

Koye DN, Magliano DJ, Reid CM, Jepson C, Feldman HI, Herman WH, Shaw JE.

Am J Kidney Dis. 2018 Nov;72(5):653-661. doi: 10.1053/j.ajkd.2018.02.364. Epub 2018 May 18.

PMID:
29784612
11.

Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Grams ME, Yang W, Rebholz CM, Wang X, Porter AC, Inker LA, Horwitz E, Sondheimer JH, Hamm LL, He J, Weir MR, Jaar BG, Shafi T, Appel LJ, Hsu CY; CRIC Study Investigators.

Am J Kidney Dis. 2017 Sep;70(3):337-346. doi: 10.1053/j.ajkd.2017.01.050. Epub 2017 Mar 30.

12.

Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.

Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS.

JAMA. 2014 Jun 25;311(24):2518-2531. doi: 10.1001/jama.2014.6634.

13.

Urine Potassium Excretion, Kidney Failure, and Mortality in CKD.

Leonberg-Yoo AK, Tighiouart H, Levey AS, Beck GJ, Sarnak MJ.

Am J Kidney Dis. 2017 Mar;69(3):341-349. doi: 10.1053/j.ajkd.2016.03.431. Epub 2016 May 24.

14.

Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease.

Agarwal R, Bunaye Z, Bekele DM, Light RP.

Am J Nephrol. 2008;28(4):569-75. doi: 10.1159/000115291. Epub 2008 Feb 1.

PMID:
18239383
15.

Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.

Ryom L, Kirk O, Lundgren JD, Reiss P, Pedersen C, De Wit S, Buzunova S, Gasiorowski J, Gatell JM, Mocroft A; EuroSIDA in EuroCoord.

HIV Med. 2013 Sep;14(8):503-8. doi: 10.1111/hiv.12038. Epub 2013 Apr 16.

16.

Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.

Carrero JJ, Evans M, Szummer K, Spaak J, Lindhagen L, Edfors R, Stenvinkel P, Jacobson SH, Jernberg T.

JAMA. 2014 Mar 5;311(9):919-28. doi: 10.1001/jama.2014.1334.

PMID:
24595776
17.

Longitudinal change in estimated GFR among CKD patients: A 10-year follow-up study of an integrated kidney disease care program in Taiwan.

Tsai CW, Ting IW, Yeh HC, Kuo CC.

PLoS One. 2017 Apr 5;12(4):e0173843. doi: 10.1371/journal.pone.0173843. eCollection 2017.

18.

Urinary Fibrinogen as a Predictor of Progression of CKD.

Wang H, Zheng C, Lu Y, Jiang Q, Yin R, Zhu P, Zhou M, Liu Z.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1922-1929. doi: 10.2215/CJN.01360217. Epub 2017 Sep 13.

19.

Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Sumida K, Kwak L, Grams ME, Yamagata K, Punjabi NM, Kovesdy CP, Coresh J, Matsushita K.

Am J Kidney Dis. 2017 Nov;70(5):675-685. doi: 10.1053/j.ajkd.2017.05.021. Epub 2017 Jul 26.

20.

Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.

Rahman M, Yang W, Akkina S, Alper A, Anderson AH, Appel LJ, He J, Raj DS, Schelling J, Strauss L, Teal V, Rader DJ; CRIC Study Investigators.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1190-8. doi: 10.2215/CJN.09320913. Epub 2014 May 15.

Supplemental Content

Support Center